KaloBios Seeks Speedy Approval To Buy Chagas Drug Rights
Bankrupt biopharmaceutical company KaloBios filed a motion Tuesday in Delaware court seeking rapid approval of a bid to buy the rights to a treatment for Chagas disease in an effort to create...To view the full article, register now.
Already a subscriber? Click here to view full article